NRXP
NRx Pharmaceuticals (NRXP)
$76
About NRx Pharmaceuticals (NRXP)
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
Details
Daily high
$4.15
Daily low
$3.37
Price at open
$3.46
52 Week High
$5.06
52 Week Low
$1.62
Market cap
129.6M
Dividend yield
0.00%
Volume
3.9M
Avg. volume
863,852
P/E ratio
-2.42
NRx Pharmaceuticals News
Details
Daily high
$4.15
Daily low
$3.37
Price at open
$3.46
52 Week High
$5.06
52 Week Low
$1.62
Market cap
129.6M
Dividend yield
0.00%
Volume
3.9M
Avg. volume
863,852
P/E ratio
-2.42